Ozempic’s health benefits keep growing, but are the risks worth it?
Join Fox News for access to exclusive content and special access to select articles and premium content, all free of charge. By simply entering your email and continuing, you agree to Fox News’ Terms of Use and Privacy Policy, including their Notice of Financial Incentive. Make sure to provide a valid email address to access all the benefits. If you’re having trouble signing up, click here for further assistance.
Did you know that one in eight adults in the U.S. has taken Ozempic or another GLP-1 drug? These medications, containing semaglutide or liraglutide, are commonly prescribed to manage type 2 diabetes and obesity. Recent studies have revealed a plethora of benefits and some lesser-known risks associated with these drugs.
A groundbreaking study conducted by researchers at Washington University School of Medicine in St. Louis and the VA St. Louis Health Care System analyzed the health outcomes of over two million veterans with diabetes who were prescribed Ozempic or another GLP-1 drug between 2017 and 2023. The study, published in Nature, uncovered numerous advantages linked to Ozempic.
Some of the benefits identified included reduced risks of neurocognitive disorders like Alzheimer’s and dementia, seizures, and addiction to harmful substances such as alcohol, cannabis, stimulants, and opioids. Additionally, these drugs were found to lower the chances of suicidal ideation, self-harm, bulimia, and psychotic disorders like schizophrenia.
Lead study author Ziyad Al-Aly highlighted the wide-ranging benefits of GLP-1 drugs, extending beyond weight loss to address 42 different conditions. These medications act on receptors in the brain related to impulse control, reward, and addiction, explaining their efficacy in reducing cravings for food and addictive substances.
However, the study also revealed adverse effects associated with GLP-1 drugs, including gastrointestinal problems like nausea, vomiting, and diarrhea, as well as pancreas and kidney issues. Despite these risks, the overall benefits of these medications are substantial, particularly in reducing inflammation and promoting weight loss.
Experts like Seth Kipnis emphasized the positive impact of weight loss on overall health and well-being. While GLP-1 drugs can be beneficial for individuals trying to lose weight and combat addiction, proper nutritional education is essential to mitigate potential side effects.
Moving forward, it is crucial for individuals considering GLP-1 medications to weigh the pros and cons with their healthcare provider. These drugs are likely to become more prevalent due to their effectiveness in addressing obesity-related conditions, but careful monitoring and education are essential to ensure optimal outcomes.
Novo Nordisk, the manufacturer of Ozempic and Wegovy, emphasized their commitment to patient safety and continuous monitoring of the safety profile of their products. With a focus on improving chronic disease management, semaglutide medicines have the potential to benefit millions of individuals worldwide.
For more health-related content, visit www.foxnews.com/health and stay informed about the latest developments in healthcare and wellness. Join Fox News today to access exclusive articles and premium content that can help you make informed decisions about your health and well-being.
